Terms: = Skin cancer AND COX6C, P09669, 1345, ENSG00000164919
14 results:
1. Clusters, crop dusters, and myth busters: a scoping review of environmental exposures and cutaneous T-cell lymphoma.
Gordon ER; Adeuyan O; Schreidah CM; Chen C; Trager MH; Lapolla BA; Fahmy LM; Weng C; Geskin LJ
Ital J Dermatol Venerol; 2023 Dec; 158(6):467-482. PubMed ID: 38015484
[TBL] [Abstract] [Full Text] [Related]
2. Effects of the COVID-19 pandemic on inpatient skin surgery in Germany: results of the DESSI-survey.
Balakirski G; Hofmann SC; Isselmann N; Giordano A; Dippel E; Löser CR
J Dtsch Dermatol Ges; 2023 Jul; 21(7):727-738. PubMed ID: 37403533
[TBL] [Abstract] [Full Text] [Related]
3. Tyrosine kinase inhibitors versus radiation therapy in unresectable dermatofibrosarcoma protuberans (DFSP): A narrative systematic review.
Henry OS; Platoff R; Cerniglia KS; Batchu S; Goodwin BJ; Sandilos G; Adams A; Hong YK
Am J Surg; 2023 Feb; 225(2):268-274. PubMed ID: 36184329
[TBL] [Abstract] [Full Text] [Related]
4. Detection of a second primary cancer in a 18F-fluorocholine PET/CT - multicentre retrospective analysis on a group of 1345 prostate cancer patients.
Cegla P; Scibisz-Dziedzic K; Witkowska K; Kubiak A; Wierzchoslawska E; Kycler W; Chrapko B; Czepczyński R
Nucl Med Rev Cent East Eur; 2022; 25(1):25-30. PubMed ID: 35137934
[TBL] [Abstract] [Full Text] [Related]
5. Delayed Metastatic Polypoid Nodular Melanoma Diagnosis During COVID-19 Pandemic, Successful Treatment With Surgery and Nivolumab.
Bradu S; Siegel D; Loyal J; Leaf A; Kurtti A; Alapati U; Jagdeo J
J Drugs Dermatol; 2021 Dec; 20(12):1343-1345. PubMed ID: 34898148
[TBL] [Abstract] [Full Text] [Related]
6. Overall survival in patients with BRAF-mutant melanoma receiving encorafenib plus binimetinib versus vemurafenib or encorafenib (COLUMBUS): a multicentre, open-label, randomised, phase 3 trial.
Dummer R; Ascierto PA; Gogas HJ; Arance A; Mandala M; Liszkay G; Garbe C; Schadendorf D; Krajsova I; Gutzmer R; Chiarion Sileni V; Dutriaux C; de Groot JWB; Yamazaki N; Loquai C; Moutouh-de Parseval LA; Pickard MD; Sandor V; Robert C; Flaherty KT
Lancet Oncol; 2018 Oct; 19(10):1315-1327. PubMed ID: 30219628
[TBL] [Abstract] [Full Text] [Related]
7. MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial.
Dreno B; Thompson JF; Smithers BM; Santinami M; Jouary T; Gutzmer R; Levchenko E; Rutkowski P; Grob JJ; Korovin S; Drucis K; Grange F; Machet L; Hersey P; Krajsova I; Testori A; Conry R; Guillot B; Kruit WHJ; Demidov L; Thompson JA; Bondarenko I; Jaroszek J; Puig S; Cinat G; Hauschild A; Goeman JJ; van Houwelingen HC; Ulloa-Montoya F; Callegaro A; Dizier B; Spiessens B; Debois M; Brichard VG; Louahed J; Therasse P; Debruyne C; Kirkwood JM
Lancet Oncol; 2018 Jul; 19(7):916-929. PubMed ID: 29908991
[TBL] [Abstract] [Full Text] [Related]
8. Nivolumab versus ipilimumab in the treatment of advanced melanoma: a critical appraisal: ORIGINAL ARTICLE: Wolchok JD, Chiarion-Sileni V, Gonzalez R et al. Overall survival with combined nivolumab and ipilimumab in advanced melanoma. N Engl J Med 2017; 377:1345-56.
Wan MT; Ming ME
Br J Dermatol; 2018 Aug; 179(2):296-300. PubMed ID: 29766492
[TBL] [Abstract] [Full Text] [Related]
9. Encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF-mutant melanoma (COLUMBUS): a multicentre, open-label, randomised phase 3 trial.
Dummer R; Ascierto PA; Gogas HJ; Arance A; Mandala M; Liszkay G; Garbe C; Schadendorf D; Krajsova I; Gutzmer R; Chiarion-Sileni V; Dutriaux C; de Groot JWB; Yamazaki N; Loquai C; Moutouh-de Parseval LA; Pickard MD; Sandor V; Robert C; Flaherty KT
Lancet Oncol; 2018 May; 19(5):603-615. PubMed ID: 29573941
[TBL] [Abstract] [Full Text] [Related]
10. Risk factors for positive or equivocal margins after wide local excision of 1345 cutaneous melanomas.
Miller CJ; Shin TM; Sobanko JF; Sharkey JM; Grunyk JW; Elenitsas R; Chu EY; Capell BC; Ming ME; Etzkorn JR
J Am Acad Dermatol; 2017 Aug; 77(2):333-340.e1. PubMed ID: 28711085
[TBL] [Abstract] [Full Text] [Related]
11. Amelanotic melanoma: a detailed morphologic analysis with clinicopathologic correlation of 75 cases.
Cheung WL; Patel RR; Leonard A; Firoz B; Meehan SA
J Cutan Pathol; 2012 Jan; 39(1):33-9. PubMed ID: 22050235
[TBL] [Abstract] [Full Text] [Related]
12. Accelerated radiotherapy with concomitant boost technique (69.5 Gy/5 weeks) : an alternative in the treatment of locally advanced head and neck cancer.
Kubes J; Cvek J; Vondracek V; Pala M; Feltl D
Strahlenther Onkol; 2011 Oct; 187(10):651-5. PubMed ID: 21947124
[TBL] [Abstract] [Full Text] [Related]
13. Epithelioid angiomatous nodule of head and neck.
Sun ZJ; Cai Y; Zhao YF; Hu X; Zhang W; Chen XM; Lai FM
Pathol Res Pract; 2009; 205(11):753-7. PubMed ID: 19596525
[TBL] [Abstract] [Full Text] [Related]
14. The value of the NSD formula in equation of acute and late radiation complications in normal tissue following 2 and 5 fractions per week in breast cancer patients treated with postmastectomy irradiation.
Overgaard M; Bentzen SM; Christensen JJ; Madsen EH
Radiother Oncol; 1987 May; 9(1):1-11. PubMed ID: 3602425
[TBL] [Abstract] [Full Text] [Related]
